Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H.C. Starck Solutions, formerly known as H.C. Starck Fabricated Products, is a leading global manufacturer of high-performance metal solutions specializing in refractory metals such as tungsten, molybdenum, and tantalum. The company serves as a critical supplier to the healthcare industry, providing precision-engineered components for medical imaging systems, including X-ray targets, radiation shielding, and CT scanner parts. Their expertise in materials science enables the production of high-density materials essential for managing ionizing radiation in clinical environments. Beyond healthcare, the company provides advanced metallurgical products for the aerospace, defense, and semiconductor industries. In November 2023, H.C. Starck Solutions was acquired by Elmet Technologies, creating a major North American-based leader in the refractory metals market. The company continues to operate as a key partner for major medical device OEMs worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H.C. Starck Fabricated Products.